GPNMB (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "GPNMB" in Persian language version.

refsWebsite

Global rank Persian rank

14nih.gov

4^th place

5^th place

11doi.org

2^nd place

5semanticscholar.org

11^th place

52^nd place

1ensembl.org

1,626^th place

1,252^nd place

1handle.net

102^nd place

515^th place

1archive.today

14^th place

29^th place

1aacrjournals.org

8,869^th place

6,977^th place

1cancer.gov

1,684^th place

533^rd place

aacrjournals.org

cancerres.aacrjournals.org

Burris H, Saleh M, Bendell J, Hart L, Rose A, Dong Z, Siegel P, Crane M, Donovan D, Crowley D, Simantov R, Vahdat L (December 2009). "A Phase (Ph) I/II Study of CR011-VcMMAE, an Antibody-Drug Conjugate, in Patients (Pts) with Locally Advanced or Metastatic Breast Cancer (MBC)". Cancer Research. 69 (24 (Meeting Abstract Supplement)): 6096. doi:10.1158/0008-5472.SABCS-09-6096. Archived from the original on 2013-02-23.

archive.today

Burris H, Saleh M, Bendell J, Hart L, Rose A, Dong Z, Siegel P, Crane M, Donovan D, Crowley D, Simantov R, Vahdat L (December 2009). "A Phase (Ph) I/II Study of CR011-VcMMAE, an Antibody-Drug Conjugate, in Patients (Pts) with Locally Advanced or Metastatic Breast Cancer (MBC)". Cancer Research. 69 (24 (Meeting Abstract Supplement)): 6096. doi:10.1158/0008-5472.SABCS-09-6096. Archived from the original on 2013-02-23.

cancer.gov

NCI Drug Dictionary: Glemtumumab vedotin

doi.org

Weterman MA, Ajubi N, van Dinter IM, Degen WG, van Muijen GN, Ruitter DJ, Bloemers HP (January 1995). "nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts". International Journal of Cancer. 60 (1): 73–81. doi:10.1002/ijc.2910600111. hdl:2066/20693. PMID 7814155. S2CID 28723750.
Loftus SK, Antonellis A, Matera I, Renaud G, Baxter LL, Reid D, Wolfsberg TG, Chen Y, Wang C, Prasad MK, Bessling SL, McCallion AS, Green ED, Bennett DC, Pavan WJ (February 2009). "Gpnmb is a Melanoblast-Expressed, MITF-Dependent Gene". Pigment Cell & Melanoma Research. 22 (1): 99–110. doi:10.1111/j.1755-148X.2008.00518.x. PMC 2714741. PMID 18983539.
Hoek KS, Schlegel NC, Eichhoff OM, Widmer DS, Praetorius C, Einarsson SO, Valgeirsdottir S, Bergsteinsdottir K, Schepsky A, Dummer R, Steingrimsson E (December 2008). "Novel MITF targets identified using a two-step DNA microarray strategy". Pigment Cell & Melanoma Research. 21 (6): 665–76. doi:10.1111/j.1755-148X.2008.00505.x. PMID 19067971. S2CID 24698373.
Abdelmagid SM, Barbe MF, Rico MC, Salihoglu S, Arango-Hisijara I, Selim AH, Anderson MG, Owen TA, Popoff SN, Safadi FF (1 August 2008). "Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function". Exp Cell Res. 314 (13): 2334–51. doi:10.1016/j.yexcr.2008.02.006. PMID 18555216.
Abdelmagid SM, Barbe MF, Arango-Hisijara I, Owen TA, Popoff SN, Safadi FF (2007). "Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function". J. Cell. Physiol. 210 (1): 26–37. doi:10.1002/jcp.20841. PMID 17034042. S2CID 24661488.
Abdelmagid SM, Barbe MF, Hadjiargyrou M, Owen TA, Razmpour R, Rehman S, Popoff SN, Safadi FF (1 Oct 2010). "Temporal and spatial expression of osteoactivin during fracture repair". J Cell Biochem. 111 (2): 295–309. doi:10.1002/jcb.22702. PMID 20506259. S2CID 28916051.
Sheng MH, Wergedal JE, Mohan S, Lau KH (October 2008). "Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity". FEBS Lett. 582 (10): 1451–8. doi:10.1016/j.febslet.2008.03.030. PMID 18381073. S2CID 12655085.
Tse KF, Jeffers M, Pollack VA, McCabe DA, Shadish ML, Khramtsov NV, Hackett CS, Shenoy SG, Kuang B, Boldog FL, MacDougall JR, Rastelli L, Herrmann J, Gallo M, Gazit-Bornstein G, Senter PD, Meyer DL, Lichenstein HS, LaRochelle WJ (February 2006). "CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma". Clinical Cancer Research. 12 (4): 1373–82. doi:10.1158/1078-0432.CCR-05-2018. PMID 16489096.
Kuan CT, Wakiya K, Dowell JM, Herndon JE, Reardon DA, Graner MW, Riggins GJ, Wikstrand CJ, Bigner DD (April 2006). "Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme". Clinical Cancer Research. 12 (7 Pt 1): 1970–82. doi:10.1158/1078-0432.CCR-05-2797. PMID 16609006.
Rose AA, Pepin F, Russo C, Abou Khalil JE, Hallett M, Siegel PM (October 2007). "Osteoactivin promotes breast cancer metastasis to bone". Molecular Cancer Research. 5 (10): 1001–14. doi:10.1158/1541-7786.MCR-07-0119. PMID 17951401.
Burris H, Saleh M, Bendell J, Hart L, Rose A, Dong Z, Siegel P, Crane M, Donovan D, Crowley D, Simantov R, Vahdat L (December 2009). "A Phase (Ph) I/II Study of CR011-VcMMAE, an Antibody-Drug Conjugate, in Patients (Pts) with Locally Advanced or Metastatic Breast Cancer (MBC)". Cancer Research. 69 (24 (Meeting Abstract Supplement)): 6096. doi:10.1158/0008-5472.SABCS-09-6096. Archived from the original on 2013-02-23.

ensembl.org

May2017.archive.ensembl.org

GRCm38: Ensembl release 89: ENSMUSG00000029816 - Ensembl, May 2017

handle.net

hdl.handle.net

Weterman MA, Ajubi N, van Dinter IM, Degen WG, van Muijen GN, Ruitter DJ, Bloemers HP (January 1995). "nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts". International Journal of Cancer. 60 (1): 73–81. doi:10.1002/ijc.2910600111. hdl:2066/20693. PMID 7814155. S2CID 28723750.

nih.gov

pubmed.ncbi.nlm.nih.gov

Weterman MA, Ajubi N, van Dinter IM, Degen WG, van Muijen GN, Ruitter DJ, Bloemers HP (January 1995). "nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts". International Journal of Cancer. 60 (1): 73–81. doi:10.1002/ijc.2910600111. hdl:2066/20693. PMID 7814155. S2CID 28723750.
Loftus SK, Antonellis A, Matera I, Renaud G, Baxter LL, Reid D, Wolfsberg TG, Chen Y, Wang C, Prasad MK, Bessling SL, McCallion AS, Green ED, Bennett DC, Pavan WJ (February 2009). "Gpnmb is a Melanoblast-Expressed, MITF-Dependent Gene". Pigment Cell & Melanoma Research. 22 (1): 99–110. doi:10.1111/j.1755-148X.2008.00518.x. PMC 2714741. PMID 18983539.
Hoek KS, Schlegel NC, Eichhoff OM, Widmer DS, Praetorius C, Einarsson SO, Valgeirsdottir S, Bergsteinsdottir K, Schepsky A, Dummer R, Steingrimsson E (December 2008). "Novel MITF targets identified using a two-step DNA microarray strategy". Pigment Cell & Melanoma Research. 21 (6): 665–76. doi:10.1111/j.1755-148X.2008.00505.x. PMID 19067971. S2CID 24698373.
Abdelmagid SM, Barbe MF, Rico MC, Salihoglu S, Arango-Hisijara I, Selim AH, Anderson MG, Owen TA, Popoff SN, Safadi FF (1 August 2008). "Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function". Exp Cell Res. 314 (13): 2334–51. doi:10.1016/j.yexcr.2008.02.006. PMID 18555216.
Abdelmagid SM, Barbe MF, Arango-Hisijara I, Owen TA, Popoff SN, Safadi FF (2007). "Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function". J. Cell. Physiol. 210 (1): 26–37. doi:10.1002/jcp.20841. PMID 17034042. S2CID 24661488.
Abdelmagid SM, Barbe MF, Hadjiargyrou M, Owen TA, Razmpour R, Rehman S, Popoff SN, Safadi FF (1 Oct 2010). "Temporal and spatial expression of osteoactivin during fracture repair". J Cell Biochem. 111 (2): 295–309. doi:10.1002/jcb.22702. PMID 20506259. S2CID 28916051.
Sheng MH, Wergedal JE, Mohan S, Lau KH (October 2008). "Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity". FEBS Lett. 582 (10): 1451–8. doi:10.1016/j.febslet.2008.03.030. PMID 18381073. S2CID 12655085.
Tse KF, Jeffers M, Pollack VA, McCabe DA, Shadish ML, Khramtsov NV, Hackett CS, Shenoy SG, Kuang B, Boldog FL, MacDougall JR, Rastelli L, Herrmann J, Gallo M, Gazit-Bornstein G, Senter PD, Meyer DL, Lichenstein HS, LaRochelle WJ (February 2006). "CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma". Clinical Cancer Research. 12 (4): 1373–82. doi:10.1158/1078-0432.CCR-05-2018. PMID 16489096.
Kuan CT, Wakiya K, Dowell JM, Herndon JE, Reardon DA, Graner MW, Riggins GJ, Wikstrand CJ, Bigner DD (April 2006). "Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme". Clinical Cancer Research. 12 (7 Pt 1): 1970–82. doi:10.1158/1078-0432.CCR-05-2797. PMID 16609006.
Rose AA, Pepin F, Russo C, Abou Khalil JE, Hallett M, Siegel PM (October 2007). "Osteoactivin promotes breast cancer metastasis to bone". Molecular Cancer Research. 5 (10): 1001–14. doi:10.1158/1541-7786.MCR-07-0119. PMID 17951401.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: GPNMB glycoprotein (transmembrane) nmb".
Loftus SK, Antonellis A, Matera I, Renaud G, Baxter LL, Reid D, Wolfsberg TG, Chen Y, Wang C, Prasad MK, Bessling SL, McCallion AS, Green ED, Bennett DC, Pavan WJ (February 2009). "Gpnmb is a Melanoblast-Expressed, MITF-Dependent Gene". Pigment Cell & Melanoma Research. 22 (1): 99–110. doi:10.1111/j.1755-148X.2008.00518.x. PMC 2714741. PMID 18983539.

semanticscholar.org

api.semanticscholar.org

Weterman MA, Ajubi N, van Dinter IM, Degen WG, van Muijen GN, Ruitter DJ, Bloemers HP (January 1995). "nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts". International Journal of Cancer. 60 (1): 73–81. doi:10.1002/ijc.2910600111. hdl:2066/20693. PMID 7814155. S2CID 28723750.
Hoek KS, Schlegel NC, Eichhoff OM, Widmer DS, Praetorius C, Einarsson SO, Valgeirsdottir S, Bergsteinsdottir K, Schepsky A, Dummer R, Steingrimsson E (December 2008). "Novel MITF targets identified using a two-step DNA microarray strategy". Pigment Cell & Melanoma Research. 21 (6): 665–76. doi:10.1111/j.1755-148X.2008.00505.x. PMID 19067971. S2CID 24698373.
Abdelmagid SM, Barbe MF, Arango-Hisijara I, Owen TA, Popoff SN, Safadi FF (2007). "Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function". J. Cell. Physiol. 210 (1): 26–37. doi:10.1002/jcp.20841. PMID 17034042. S2CID 24661488.
Abdelmagid SM, Barbe MF, Hadjiargyrou M, Owen TA, Razmpour R, Rehman S, Popoff SN, Safadi FF (1 Oct 2010). "Temporal and spatial expression of osteoactivin during fracture repair". J Cell Biochem. 111 (2): 295–309. doi:10.1002/jcb.22702. PMID 20506259. S2CID 28916051.
Sheng MH, Wergedal JE, Mohan S, Lau KH (October 2008). "Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity". FEBS Lett. 582 (10): 1451–8. doi:10.1016/j.febslet.2008.03.030. PMID 18381073. S2CID 12655085.